The effect of selenium on immunogenicity of influenza vaccine in the elderly: A case-control double-blinded clinical trial
No Thumbnail Available
Files
Date
2016-06-20
Journal Title
Journal ISSN
Volume Title
Publisher
Brieflands
Abstract
Introduction: Influenza can cause more severe diseases and higher rate of morbidity and mortality in the elderly population. Therefore, they should receive influenza vaccine annually. However, the host response to vaccine is less in older individuals. On the other hand, selenium can act as a stimulator of the immune system and cause increased immunity and response to vaccine. This study was carried out to determine the effect of selenium on antibody production against influenza vaccine. By verifying this effect, selenium can be recommended as an adjuvant therapy in the elderly.